BioTricity Inc. Files 8-K on Financials
Ticker: BTCY · Form: 8-K · Filed: Nov 20, 2024 · CIK: 1630113
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
BioTricity dropped an 8-K on Nov 15th covering financials. Check it out.
AI Summary
BioTricity Inc. filed an 8-K on November 20, 2024, reporting on its results of operations and financial condition as of November 15, 2024. The filing includes financial statements and exhibits related to the company's performance.
Why It Matters
This 8-K filing provides investors with crucial updates on BioTricity Inc.'s financial health and operational results, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- BIOTRICITY INC. (company) — Registrant
- November 15, 2024 (date) — Date of earliest event reported
- November 20, 2024 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- Redwood City, California (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on BioTricity Inc.'s results of operations and financial condition.
On what date is the earliest event reported in this filing?
The earliest event reported in this filing is dated November 15, 2024.
When was this 8-K form filed with the SEC?
This 8-K form was filed with the SEC on November 20, 2024.
In which state was BioTricity Inc. incorporated?
BioTricity Inc. was incorporated in Nevada.
What is the business address of BioTricity Inc.?
The business address of BioTricity Inc. is 203 Redwood Shores Parkway, Suite 600, Redwood City, California 94065.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-11-19 21:41:45
Filing Documents
- form8-k.htm (8-K) — 33KB
- ex99-1.htm (EX-99.1) — 31KB
- 0001493152-24-046908.txt ( ) — 238KB
- btcy-20241115.xsd (EX-101.SCH) — 3KB
- btcy-20241115_lab.xml (EX-101.LAB) — 33KB
- btcy-20241115_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: November 20, 2024 BIOTRICITY INC. By: /s/ Waqaas Al-Siddiq Waqaas Al-Siddiq Chief Executive Officer